BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 9454885)

  • 1. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
    Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
    Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
    Lee FT; Hall C; Rigopoulos A; Zweit J; Pathmaraj K; O'Keefe GJ; Smyth FE; Welt S; Old LJ; Scott AM
    J Nucl Med; 2001 May; 42(5):764-9. PubMed ID: 11337573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance kinetics and external dosimetry of 131I-labeled murine and humanized monoclonal antibody A33 in patients with colon cancer: radiation safety implications.
    Dauer LT; Boylan DC; Williamson MJ; St Germain J; Larson SM
    Health Phys; 2009 May; 96(5):550-7. PubMed ID: 19359848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts.
    Deckert PM; Jungbluth A; Montalto N; Clark MA; Finn RD; Williams C; Richards EC; Panageas KS; Old LJ; Welt S
    Int J Cancer; 2000 Aug; 87(3):382-90. PubMed ID: 10897044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft.
    Barendswaard EC; Humm JL; O'Donoghue JA; Sgouros G; Finn RD; Scott AM; Larson SM; Welt S
    J Nucl Med; 2001 Aug; 42(8):1251-6. PubMed ID: 11483688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
    Deckert PM; Bornmann WG; Ritter G; Williams C; Franke J; Keilholz U; Thiel E; Old LJ; Bertino JR; Welt S
    Int J Oncol; 2004 May; 24(5):1289-95. PubMed ID: 15067353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
    Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
    Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Divgi CR; Kemeny N; Finn RD; Scott AM; Graham M; Germain JS; Richards EC; Larson SM; Oettgen HF
    J Clin Oncol; 1994 Aug; 12(8):1561-71. PubMed ID: 8040668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Scott AM; Divgi CR; Kemeny NE; Finn RD; Daghighian F; Germain JS; Richards EC; Larson SM; Old LJ
    J Clin Oncol; 1996 Jun; 14(6):1787-97. PubMed ID: 8656247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pre-irradiation on monoclonal antibody localization in colon tumor xenografts expressing a cell-associated antigen.
    Gridley DS; Slater JB; Slater JM
    Anticancer Res; 1995; 15(1):99-104. PubMed ID: 7733650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
    Welt S; Divgi CR; Real FX; Yeh SD; Garin-Chesa P; Finstad CL; Sakamoto J; Cohen A; Sigurdson ER; Kemeny N
    J Clin Oncol; 1990 Nov; 8(11):1894-906. PubMed ID: 2230877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
    J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 111Indium-labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin.
    Hassan R; Wu C; Brechbiel MW; Margulies I; Kreitman RJ; Pastan I
    Int J Cancer; 1999 Feb; 80(4):559-63. PubMed ID: 9935157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
    Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
    Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
    Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
    Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.